Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. MacDonald, BR
   Emerging therapies in osteoporosis
   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
   
   B.R. MacDonald, "Emerging therapies in osteoporosis", BEST PR R C, 15(3), 2001, pp. 483-496
2. Elder, GJ
   Pathogenesis and management of hyperparathyroidism in end-stage renal disease and after renal transplantation
   NEPHROLOGY
   
   G.J. Elder, "Pathogenesis and management of hyperparathyroidism in end-stage renal disease and after renal transplantation", NEPHROLOGY, 6(4), 2001, pp. 155-160
3. Mokuda, O; Okazaki, R; Sakamoto, Y
   The early phase of calcipenia-induced parathyroid hormone secretion is blunted in vasculary perfused parathyroid glands of streptozotocin-diabetic rats'
   DIABETES & METABOLISM
   
   O. Mokuda et al., "The early phase of calcipenia-induced parathyroid hormone secretion is blunted in vasculary perfused parathyroid glands of streptozotocin-diabetic rats'", DIABETE MET, 27(2), 2001, pp. 129-131
4. Goodman, WG
   Calcimimetic agents for the treatment of hyperparathyroidism
   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
   
   W.G. Goodman, "Calcimimetic agents for the treatment of hyperparathyroidism", CURR OP NEP, 10(5), 2001, pp. 575-580
5. Grimm, M; Muller, A; Hein, G; Funfstuck, R; Jahreis, G
   High phosphorus intake only slightly affects serum minerals, urinary pyridinium crosslinks and renal function in young women
   EUROPEAN JOURNAL OF CLINICAL NUTRITION
   
   M. Grimm et al., "High phosphorus intake only slightly affects serum minerals, urinary pyridinium crosslinks and renal function in young women", EUR J CL N, 55(3), 2001, pp. 153-161
6. McVicar, CM; Cunningham, RT; Harriott, P; Johnston, CF; Buchanan, KD; Curry, WJ
   Analysis of the post-translational processing of chromogranin a in rat neuroendocrine tissue employing an N-terminal site-specific antiserum
   JOURNAL OF NEUROENDOCRINOLOGY
   
   C.M. McVicar et al., "Analysis of the post-translational processing of chromogranin a in rat neuroendocrine tissue employing an N-terminal site-specific antiserum", J NEUROENDO, 13(7), 2001, pp. 588-595
7. De Cristofaro, V; Colturi, C; Masa, A; Comelli, M; Pedrini, LA
   Rate dependence of acute PTH release and association between basal plasma calcium and set point of calcium-PTH curve in dialysis patients
   NEPHROLOGY DIALYSIS TRANSPLANTATION
   
   V. De Cristofaro et al., "Rate dependence of acute PTH release and association between basal plasma calcium and set point of calcium-PTH curve in dialysis patients", NEPH DIAL T, 16(6), 2001, pp. 1214-1221
8. Jara, A; Chacon, C; Valdivieso, A; Aris, L; Jalil, R; Felsenfeld, AJ
   Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia
   NEPHROLOGY DIALYSIS TRANSPLANTATION
   
   A. Jara et al., "Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia", NEPH DIAL T, 16(5), 2001, pp. 1009-1016
9. Lamberg-Allardt, CJE; Outila, TA; Karkkainen, MUM; Rita, HJ; Valsta, LM
   Vitamin D deficiency and bone health in healthy adults in finland: Could this be a concern in other parts of Europe?
   JOURNAL OF BONE AND MINERAL RESEARCH
   
   C.J.E. Lamberg-Allardt et al., "Vitamin D deficiency and bone health in healthy adults in finland: Could this be a concern in other parts of Europe?", J BONE MIN, 16(11), 2001, pp. 2066-2073
10. Carlstedt, F; Lind, L
    Hypocalcemic syndromes
    CRITICAL CARE CLINICS
    
    F. Carlstedt e L. Lind, "Hypocalcemic syndromes", CRIT CARE C, 17(1), 2001, pp. 139
11. Sax, L
    The institute of medicine's "dietary reference intake" for phosphorus: A critical perspective
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
    
    L. Sax, "The institute of medicine's "dietary reference intake" for phosphorus: A critical perspective", J AM COL N, 20(4), 2001, pp. 271-278
12. Breitwieser, GE; Gama, L
    Calcium-sensing receptor activation induces intracellular calcium oscillations
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    
    G.E. Breitwieser e L. Gama, "Calcium-sensing receptor activation induces intracellular calcium oscillations", AM J P-CELL, 280(6), 2001, pp. C1412-C1421
13. Yamauchi, M; Sugimoto, T; Yamaguchi, T; Yano, S; Kanzawa, M; Kobayashi, A; Chihara, K
    Association of polymorphic alleles of the calcium-sensing receptor gene with the clinical severity of primary hyperparathyroidism
    CLINICAL ENDOCRINOLOGY
    
    M. Yamauchi et al., "Association of polymorphic alleles of the calcium-sensing receptor gene with the clinical severity of primary hyperparathyroidism", CLIN ENDOCR, 55(3), 2001, pp. 373-379
14. Oleksik, A; Duong, T; Popp-Snijders, C; Pliester, N; Asma, G; Lips, P
    Effects of the selective oestrogen receptor modulator-raloxifene-on calcium and PTH secretory dynamics in women with osteoporosis
    CLINICAL ENDOCRINOLOGY
    
    A. Oleksik et al., "Effects of the selective oestrogen receptor modulator-raloxifene-on calcium and PTH secretory dynamics in women with osteoporosis", CLIN ENDOCR, 54(5), 2001, pp. 575-582
15. Martin, KJ; Gonzalez, EA
    Strategies to minimize bone disease in renal failure
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    K.J. Martin e E.A. Gonzalez, "Strategies to minimize bone disease in renal failure", AM J KIDNEY, 38(6), 2001, pp. 1430-1436
16. Llach, F; Forero, FV
    Secondary hyperparathyroidism in chronic renal failure: Pathogenic and clinical aspects
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    F. Llach e F.V. Forero, "Secondary hyperparathyroidism in chronic renal failure: Pathogenic and clinical aspects", AM J KIDNEY, 38(5), 2001, pp. S20-S33
17. Zivin, JR; Gooley, T; Zager, RA; Ryan, MJ
    Hypocalcemia: A pervasive metabolic abnormality in the critically ill
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    J.R. Zivin et al., "Hypocalcemia: A pervasive metabolic abnormality in the critically ill", AM J KIDNEY, 37(4), 2001, pp. 689-698
18. Hauache, OM
    Extracellular calcium-sensing receptor: structural and functional featuresand association with diseases
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    
    O.M. Hauache, "Extracellular calcium-sensing receptor: structural and functional featuresand association with diseases", BRAZ J MED, 34(5), 2001, pp. 577-584
19. Tfelt-Hansen, J; Schwarz, P; Torring, O
    Rapid suppression of S-PTH by oral calcitriol and calcium in healthy premenopausal women
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    
    J. Tfelt-Hansen et al., "Rapid suppression of S-PTH by oral calcitriol and calcium in healthy premenopausal women", SC J CL INV, 61(5), 2001, pp. 395-400
20. Handlogten, ME; Huang, CF; Shiraishi, N; Awata, H; Miller, RT
    The Ca2+-sensing receptor activates cytosolic phospholipase A(2) via a G(q)alpha-dependent ERK-independent pathway
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    M.E. Handlogten et al., "The Ca2+-sensing receptor activates cytosolic phospholipase A(2) via a G(q)alpha-dependent ERK-independent pathway", J BIOL CHEM, 276(17), 2001, pp. 13941-13948
21. Bush, WW; Kimmel, SE; Wosar, MA; Jackson, MW
    Secondary hypoparathyroidism attributed to hypomagnesemia in a dog with protein-losing enteropathy
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
    
    W.W. Bush et al., "Secondary hypoparathyroidism attributed to hypomagnesemia in a dog with protein-losing enteropathy", J AM VET ME, 219(12), 2001, pp. 1732
22. Karkkainen, MUM; Lamberg-Allardt, CJE; Ahonen, S; Valimaki, M
    Does it make a difference how and when you take your calcium? The acute effects of calcium on calcium and bone metabolism
    AMERICAN JOURNAL OF CLINICAL NUTRITION
    
    M.U.M. Karkkainen et al., "Does it make a difference how and when you take your calcium? The acute effects of calcium on calcium and bone metabolism", AM J CLIN N, 74(3), 2001, pp. 335-342
23. Calvo, MS
    Dietary considerations to prevent loss of bone and renal function
    NUTRITION
    
    M.S. Calvo, "Dietary considerations to prevent loss of bone and renal function", NUTRITION, 16(7-8), 2000, pp. 564-566
24. Wilson, RB; Erskine, C; Crowe, PJ
    Hypomagnesemia and hypocalcemia after thyroidectomy: Prospective study
    WORLD JOURNAL OF SURGERY
    
    R.B. Wilson et al., "Hypomagnesemia and hypocalcemia after thyroidectomy: Prospective study", WORLD J SUR, 24(6), 2000, pp. 722-726
25. Bergenfelz, A; Luts, L; Jensen, TB; Sundler, F
    Pancreastatin plasma levels in patients with primary hyperparathyroidism
    WORLD JOURNAL OF SURGERY
    
    A. Bergenfelz et al., "Pancreastatin plasma levels in patients with primary hyperparathyroidism", WORLD J SUR, 24(12), 2000, pp. 1579-1583
26. Herman, EH; Zhang, J; Chadwick, DP; Ferrans, VJ
    Comparison of the protective effects of amifostine and dexrazoxane againstthe toxicity of doxorubicin in spontaneously hypertensive rats
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    E.H. Herman et al., "Comparison of the protective effects of amifostine and dexrazoxane againstthe toxicity of doxorubicin in spontaneously hypertensive rats", CANC CHEMOT, 45(4), 2000, pp. 329-334
27. Sanchez, MC; Bajo, MA; Selgas, R; Mate, A; Millan, I; Martinez, ME; Lopez-Barea, F
    Parathormone secretion in peritoneal dialysis patients with adynamic bone disease
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    M.C. Sanchez et al., "Parathormone secretion in peritoneal dialysis patients with adynamic bone disease", AM J KIDNEY, 36(5), 2000, pp. 953-961
28. Oktenli, C
    Renal magnesium wasting, hypomagnesemic hypocalcemia, hypocalciuria and osteopenia in a patient with glycogenosis type II
    AMERICAN JOURNAL OF NEPHROLOGY
    
    C. Oktenli, "Renal magnesium wasting, hypomagnesemic hypocalcemia, hypocalciuria and osteopenia in a patient with glycogenosis type II", AM J NEPHR, 20(5), 2000, pp. 412-417
29. Hertig, A; Maruani, G; Paillard, M; Houillier, P
    Primary hyperparathyroidism
    NEPHROLOGIE
    
    A. Hertig et al., "Primary hyperparathyroidism", NEPHROLOGIE, 21(6), 2000, pp. 283-290
30. Giraldez, EF
    Present dilemmas and future trens in renal osteodistrophy therapy
    NEFROLOGIA
    
    E.F. Giraldez, "Present dilemmas and future trens in renal osteodistrophy therapy", NEFROLOGIA, 20, 2000, pp. 41-51
31. Yano, S; Sugimoto, T; Kanzawa, M; Tsukamoto, T; Hattori, T; Hattori, S; Chihara, K
    Association of polymorphic alleles of the calcium-sensing receptor gene with parathyroid hormone secretion in hemodialysis patients
    NEPHRON
    
    S. Yano et al., "Association of polymorphic alleles of the calcium-sensing receptor gene with parathyroid hormone secretion in hemodialysis patients", NEPHRON, 85(4), 2000, pp. 317-323
32. Basso, LE; Ubbink, JB; Delport, R; Spies, J; Vermaak, WJH
    Effect of magnesium supplementation on the fractional intestinal absorption of (CaCl2)-Ca-45 in women with a low erythrocyte magnesium concentration
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    L.E. Basso et al., "Effect of magnesium supplementation on the fractional intestinal absorption of (CaCl2)-Ca-45 in women with a low erythrocyte magnesium concentration", METABOLISM, 49(8), 2000, pp. 1092-1096
33. Andia, JBC
    Adynamic bone and chronic renal failure: An overview
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    
    J.B.C. Andia, "Adynamic bone and chronic renal failure: An overview", AM J MED SC, 320(2), 2000, pp. 81-84
34. Fox, J; Lowe, SH; Conklin, RL; Nemeth, EF
    The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism
    ENDOCRINE
    
    J. Fox et al., "The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism", ENDOCRINE, 10(2), 1999, pp. 97-103
35. Finch, JL; Brown, AJ; Slatopolsey, E
    Differential effects of 1,25-dihydroxy-vitamin D-3 and 19-nor-1,25-dihydroxy-vitamin D-2 on calcium and phosphorus resorption in bone
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    J.L. Finch et al., "Differential effects of 1,25-dihydroxy-vitamin D-3 and 19-nor-1,25-dihydroxy-vitamin D-2 on calcium and phosphorus resorption in bone", J AM S NEPH, 10(5), 1999, pp. 980-985
36. Rude, RK; Kirchen, ME; Gruber, HE; Meyer, MH; Luck, JS; Crawford, DL
    Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption
    MAGNESIUM RESEARCH
    
    R.K. Rude et al., "Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption", MAGNES RES, 12(4), 1999, pp. 257-267
37. Boncimino, K; McMahon, DJ; Addesso, V; Bilezikian, JP; Shane, E
    Magnesium deficiency and bone loss after cardiac transplantation
    JOURNAL OF BONE AND MINERAL RESEARCH
    
    K. Boncimino et al., "Magnesium deficiency and bone loss after cardiac transplantation", J BONE MIN, 14(2), 1999, pp. 295-303
38. Cannella, G; Messa, P
    Pathogenesis and treatment of secondary hyperparathyroidism in chronic renal disease
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    
    G. Cannella e P. Messa, "Pathogenesis and treatment of secondary hyperparathyroidism in chronic renal disease", INT J ARTIF, 22(1), 1999, pp. 1-7
39. Brown, AJ; Dusso, A; Slatopolsky, E
    Vitamin D
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    
    A.J. Brown et al., "Vitamin D", AM J P-REN, 46(2), 1999, pp. F157-F175
40. Chang, W; Pratt, S; Chen, TH; Shoback, D
    Protein kinase C activation blocks calcium receptor signaling in Xenopus laevis oocytes
    MOLECULAR AND CELLULAR ENDOCRINOLOGY
    
    W. Chang et al., "Protein kinase C activation blocks calcium receptor signaling in Xenopus laevis oocytes", MOL C ENDOC, 158(1-2), 1999, pp. 13-23
41. Schumann, K
    Interactions between drugs and vitamins at advanced age
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
    
    K. Schumann, "Interactions between drugs and vitamins at advanced age", INT J VIT N, 69(3), 1999, pp. 173-178
42. Borrego, MJ; Martin-Malo, A; Almaden, Y; Rodriguez, M; Aljama, P; Felsenfeld, AJ
    Effect of calcitriol and age on recovery from hypocalcemia in hemodialysispatients
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    M.J. Borrego et al., "Effect of calcitriol and age on recovery from hypocalcemia in hemodialysispatients", AM J KIDNEY, 34(3), 1999, pp. 456-463
43. Schacht, E
    Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol
    CALCIFIED TISSUE INTERNATIONAL
    
    E. Schacht, "Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol", CALCIF TIS, 65(4), 1999, pp. 317-327
44. Slatopolsky, E; Dusso, A; Brown, A
    New analogs of vitamin D-3
    KIDNEY INTERNATIONAL
    
    E. Slatopolsky et al., "New analogs of vitamin D-3", KIDNEY INT, 56, 1999, pp. S46-S51
45. Couttenye, MM; D'Haese, PC; Verschoren, WJ; Behets, GJ; Schrooten, I; De Broe, ME
    Low bone turnover in patients with renal failure
    KIDNEY INTERNATIONAL
    
    M.M. Couttenye et al., "Low bone turnover in patients with renal failure", KIDNEY INT, 56, 1999, pp. S70-S76
46. Gaudilliere, B
    To market, to market - 1998
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34
    
    B. Gaudilliere, "To market, to market - 1998", ANNU REP M, 34, 1999, pp. 317-338
47. Stohlawetz, P; Kapiotis, S; Seidl, D; Hergovich, N; Zellner, M; Eichler, HG; Stiegler, G; Leitner, G; Hocker, P; Jilma, B
    Safety issues of plateletpheresis: comparison of the effects of two cell separators on the activation of coagulation, fibrinolysis, and neutrophils and on the formation of neutrophil-platelet aggregates
    TRANSFUSION
    
    P. Stohlawetz et al., "Safety issues of plateletpheresis: comparison of the effects of two cell separators on the activation of coagulation, fibrinolysis, and neutrophils and on the formation of neutrophil-platelet aggregates", TRANSFUSION, 39(4), 1999, pp. 420-427
48. Martini, LA
    Magnesium supplementation and bone turnover
    NUTRITION REVIEWS
    
    L.A. Martini, "Magnesium supplementation and bone turnover", NUTR REV, 57(7), 1999, pp. 227-229
49. Morris, JG; Earle, KE
    Growing kittens require less dietary calcium than current allowances
    JOURNAL OF NUTRITION
    
    J.G. Morris e K.E. Earle, "Growing kittens require less dietary calcium than current allowances", J NUTR, 129(9), 1999, pp. 1698-1704
50. Lalonde, RL; Gaudreault, J; Karhu, DA; Marriott, TB
    Mixed-effects modeling of the pharmacodynamic response to the calcimimeticagent R-568
    CLINICAL PHARMACOLOGY & THERAPEUTICS
    
    R.L. Lalonde et al., "Mixed-effects modeling of the pharmacodynamic response to the calcimimeticagent R-568", CLIN PHARM, 65(1), 1999, pp. 40-49
51. Perheentupa, J; Miettinen, A
    Type 1 autoimmune polyglandular disease
    ANNALES DE MEDECINE INTERNE
    
    J. Perheentupa e A. Miettinen, "Type 1 autoimmune polyglandular disease", ANN MED IN, 150(4), 1999, pp. 313-325
52. SCHMITT CP; HUBER D; MEHLS O; MAIWALD J; STEIN G; VELDHUIS JD; RITZ E; SCHAEFER F
    ALTERED INSTANTANEOUS AND CALCIUM-MODULATED OSCILLATORY PTH SECRETIONPATTERNS IN PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
    Journal of the American Society of Nephrology
    
    C.P. Schmitt et al., "ALTERED INSTANTANEOUS AND CALCIUM-MODULATED OSCILLATORY PTH SECRETIONPATTERNS IN PATIENTS WITH SECONDARY HYPERPARATHYROIDISM", Journal of the American Society of Nephrology, 9(10), 1998, pp. 1832-1844
53. HORY B; ROUSSANNE MC; DRUEKE TB; BOURDEAU A
    THE CALCIUM RECEPTOR IN HEALTH AND DISEASE
    Experimental nephrology
    
    B. Hory et al., "THE CALCIUM RECEPTOR IN HEALTH AND DISEASE", Experimental nephrology, 6(3), 1998, pp. 171-179
54. WHYBRO A; JAGGER H; BARKER M; EASTELL R
    PHOSPHATE SUPPLEMENTATION IN YOUNG MEN - LACK OF EFFECT ON CALCIUM HOMEOSTASIS AND BONE TURNOVER
    European journal of clinical nutrition
    
    A. Whybro et al., "PHOSPHATE SUPPLEMENTATION IN YOUNG MEN - LACK OF EFFECT ON CALCIUM HOMEOSTASIS AND BONE TURNOVER", European journal of clinical nutrition, 52(1), 1998, pp. 29-33
55. CHERTOW GM; MARTIN KJ
    CURRENT AND FUTURE THERAPIES FOR THE MEDICAL-MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM
    Seminars in dialysis
    
    G.M. Chertow e K.J. Martin, "CURRENT AND FUTURE THERAPIES FOR THE MEDICAL-MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM", Seminars in dialysis, 11(5), 1998, pp. 267-270
56. RIGGS BL; KHOSLA S; MELTON LJ
    A UNITARY MODEL FOR INVOLUTIONAL OSTEOPOROSIS - ESTROGEN DEFICIENCY CAUSES BOTH TYPE-I AND TYPE-II OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN ANDCONTRIBUTES TO BONE LOSS IN AGING MEN
    Journal of bone and mineral research
    
    B.L. Riggs et al., "A UNITARY MODEL FOR INVOLUTIONAL OSTEOPOROSIS - ESTROGEN DEFICIENCY CAUSES BOTH TYPE-I AND TYPE-II OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN ANDCONTRIBUTES TO BONE LOSS IN AGING MEN", Journal of bone and mineral research, 13(5), 1998, pp. 763-773
57. RUDE RK
    MAGNESIUM-DEFICIENCY - A CAUSE OF HETEROGENOUS DISEASE IN HUMANS
    Journal of bone and mineral research
    
    R.K. Rude, "MAGNESIUM-DEFICIENCY - A CAUSE OF HETEROGENOUS DISEASE IN HUMANS", Journal of bone and mineral research, 13(4), 1998, pp. 749-758
58. Couttenye, MM; D'Haese, PC; De Broe, ME
    What considerations should we give to adynamic bone disease?
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    
    M.M. Couttenye et al., "What considerations should we give to adynamic bone disease?", INT J ARTIF, 21(11), 1998, pp. 687-692
59. RUDE RK; KIRCHEN ME; GRUBER HE; STASKY AA; MEYER MH
    MAGNESIUM-DEFICIENCY INDUCES BONE LOSS IN THE RAT
    Mineral and electrolyte metabolism
    
    R.K. Rude et al., "MAGNESIUM-DEFICIENCY INDUCES BONE LOSS IN THE RAT", Mineral and electrolyte metabolism, 24(5), 1998, pp. 314-320
60. HARDYYVERNEAU P; SHENOUDA M; MORINIERE P; LEGALLAIS C; BRAZIER M; ACHARD J; FOURNIER A
    THE DEPENDENCY OF CALCIUM SET-POINT ON BASAL PLASMA CALCIUM IN DIALYSIS PATIENTS - A BETTER EXPLANATION FOR THE DISCREPANCIES REGARDING ITSLINK WITH PTH SECRETION THAN METHODOLOGICAL DIFFERENCES
    Clinical nephrology
    
    P. Hardyyverneau et al., "THE DEPENDENCY OF CALCIUM SET-POINT ON BASAL PLASMA CALCIUM IN DIALYSIS PATIENTS - A BETTER EXPLANATION FOR THE DISCREPANCIES REGARDING ITSLINK WITH PTH SECRETION THAN METHODOLOGICAL DIFFERENCES", Clinical nephrology, 50(4), 1998, pp. 236-246
61. GRAAL MB; WOLFFENBUTTEL BHR
    CONSEQUENCES OF LONG-TERM HYPERPARATHYROIDISM
    Netherlands journal of medicine
    
    M.B. Graal e B.H.R. Wolffenbuttel, "CONSEQUENCES OF LONG-TERM HYPERPARATHYROIDISM", Netherlands journal of medicine, 53(1), 1998, pp. 37-42
62. LLACH F; YUDD M
    PATHOGENIC, CLINICAL, AND THERAPEUTIC ASPECTS OF SECONDARY HYPERPARATHYROIDISM IN CHRONIC-RENAL-FAILURE
    American journal of kidney diseases
    
    F. Llach e M. Yudd, "PATHOGENIC, CLINICAL, AND THERAPEUTIC ASPECTS OF SECONDARY HYPERPARATHYROIDISM IN CHRONIC-RENAL-FAILURE", American journal of kidney diseases, 32(2), 1998, pp. 3-12
63. NAVARRO JF; MORA C
    MAGNESIUM IN CHRONIC-RENAL-FAILURE
    Nefrologia
    
    J.F. Navarro e C. Mora, "MAGNESIUM IN CHRONIC-RENAL-FAILURE", Nefrologia, 18(5), 1998, pp. 375-379
64. CHANG WH; CHEN TH; PRATT S; SHOBACK D
    REGULATION OF EXTRACELLULAR CALCIUM-ACTIVATED CATION CURRENTS BY CAMPIN PARATHYROID CELLS
    American journal of physiology: endocrinology and metabolism
    
    W.H. Chang et al., "REGULATION OF EXTRACELLULAR CALCIUM-ACTIVATED CATION CURRENTS BY CAMPIN PARATHYROID CELLS", American journal of physiology: endocrinology and metabolism, 38(2), 1998, pp. 213-221
65. MIZUNASHI K; FURUKAWA Y; GOTO MM; ABE K
    SIGMOIDAL CURVE SHIFT IN IDIOPATHIC HYPOPARATHYROIDISM AND PSEUDOHYPOPARATHYROIDISM
    Calcified tissue international
    
    K. Mizunashi et al., "SIGMOIDAL CURVE SHIFT IN IDIOPATHIC HYPOPARATHYROIDISM AND PSEUDOHYPOPARATHYROIDISM", Calcified tissue international, 62(4), 1998, pp. 290-294
66. MIZUNASHI K; FURUKAWA Y; GOTO MM
    RATIO OF BASE-LINE LEVEL MAXIMUM LEVEL OF SERUM PTH IN PSEUDOHYPOPARATHYROIDISM AND PRIMARY HYPERPARATHYROIDISM
    Calcified tissue international
    
    K. Mizunashi et al., "RATIO OF BASE-LINE LEVEL MAXIMUM LEVEL OF SERUM PTH IN PSEUDOHYPOPARATHYROIDISM AND PRIMARY HYPERPARATHYROIDISM", Calcified tissue international, 62(2), 1998, pp. 99-103
67. CANNATAANDIA JB
    HYPOKINETIC AZOTEMIC OSTEODYSTROPHY
    Kidney international
    
    J.B. Cannataandia, "HYPOKINETIC AZOTEMIC OSTEODYSTROPHY", Kidney international, 54(3), 1998, pp. 1000-1016
68. DIMAI HP; PORTA S; WIRNSBERGER G; LINDSCHINGER M; PAMPERL I; DOBNIG H; WILDERSTRUSCHNIG M; LAU KHW
    DAILY ORAL MAGNESIUM SUPPLEMENTATION SUPPRESSES BONE TURNOVER IN YOUNG-ADULT MALES
    The Journal of clinical endocrinology and metabolism
    
    H.P. Dimai et al., "DAILY ORAL MAGNESIUM SUPPLEMENTATION SUPPRESSES BONE TURNOVER IN YOUNG-ADULT MALES", The Journal of clinical endocrinology and metabolism, 83(8), 1998, pp. 2742-2748
69. SHALEV H; PHILLIP M; GALIL A; CARMI R; LANDAU D
    CLINICAL PRESENTATION AND OUTCOME IN PRIMARY FAMILIAL HYPOMAGNESEMIA
    Archives of Disease in Childhood
    
    H. Shalev et al., "CLINICAL PRESENTATION AND OUTCOME IN PRIMARY FAMILIAL HYPOMAGNESEMIA", Archives of Disease in Childhood, 78(2), 1998, pp. 127-130
70. FOX J; MILLER MA; STROUP GB; NEMETH EF; MILLER SC
    PLASMA-LEVELS OF PARATHYROID-HORMONE THAT INDUCE ANABOLIC EFFECTS IN BONE OF OVARIECTOMIZED RATS CAN BE ACHIEVED BY STIMULATION OF ENDOGENOUS HORMONE-SECRETION
    Bone
    
    J. Fox et al., "PLASMA-LEVELS OF PARATHYROID-HORMONE THAT INDUCE ANABOLIC EFFECTS IN BONE OF OVARIECTOMIZED RATS CAN BE ACHIEVED BY STIMULATION OF ENDOGENOUS HORMONE-SECRETION", Bone, 21(2), 1997, pp. 163-169
71. MCKANE WR; KHOSLA S; RISTELI J; ROBINS SP; MUHS JM; RIGGS BL
    ROLE OF ESTROGEN DEFICIENCY IN PATHOGENESIS OF SECONDARY HYPERPARATHYROIDISM AND INCREASED BONE-RESORPTION IN ELDERLY WOMEN
    Proceedings of the Association of American Physicians
    
    W.R. Mckane et al., "ROLE OF ESTROGEN DEFICIENCY IN PATHOGENESIS OF SECONDARY HYPERPARATHYROIDISM AND INCREASED BONE-RESORPTION IN ELDERLY WOMEN", Proceedings of the Association of American Physicians, 109(2), 1997, pp. 174-180
72. BOUILLON R; CARMELIET G; BOONEN S
    AGING AND CALCIUM-METABOLISM
    Bailliere's clinical endocrinology and metabolism
    
    R. Bouillon et al., "AGING AND CALCIUM-METABOLISM", Bailliere's clinical endocrinology and metabolism, 11(2), 1997, pp. 341-365
73. BORREGO MJ; FELSENFELD AJ; MARTINMALO A; ALMADEN Y; CONCEPCION MT; ALJAMA P; RODRIGUEZ M
    EVIDENCE FOR ADAPTATION OF THE ENTIRE PTH-CALCIUM CURVE TO SUSTAINED CHANGES IN THE SERUM-CALCIUM IN HEMODIALYSIS-PATIENTS
    Nephrology, dialysis, transplantation
    
    M.J. Borrego et al., "EVIDENCE FOR ADAPTATION OF THE ENTIRE PTH-CALCIUM CURVE TO SUSTAINED CHANGES IN THE SERUM-CALCIUM IN HEMODIALYSIS-PATIENTS", Nephrology, dialysis, transplantation, 12(3), 1997, pp. 505-513
74. MESSA P; TURRIN D; MIONI G; CRUCIATTI A
    IMPACT OF THE METHOD OF CALCULATION ON ASSESSMENT OF THE PTH-CALCIUM SET-POINT
    Nephrology, dialysis, transplantation
    
    P. Messa et al., "IMPACT OF THE METHOD OF CALCULATION ON ASSESSMENT OF THE PTH-CALCIUM SET-POINT", Nephrology, dialysis, transplantation, 12(1), 1997, pp. 101-105
75. UBBINK JB; DELPORT R; VERMAAK WJH; VANDERMERWE A
    BIOAVAILABILITY OF CALCIUM AND MAGNESIUM FROM MAGNESIUM CITRATE CALCIUM MALATE - IMPLICATIONS FOR OSTEOPOROSIS PREVENTION
    South African medical journal
    
    J.B. Ubbink et al., "BIOAVAILABILITY OF CALCIUM AND MAGNESIUM FROM MAGNESIUM CITRATE CALCIUM MALATE - IMPLICATIONS FOR OSTEOPOROSIS PREVENTION", South African medical journal, 87(9), 1997, pp. 1271-1276
76. CARLING T; RASTAD J; KINDMARK A; LUNDGREN E; LJUNGHALL S; AKERSTROM G
    ESTROGEN-RECEPTOR GENE POLYMORPHISM IN POSTMENOPAUSAL PRIMARY HYPERPARATHYROIDISM
    Surgery
    
    T. Carling et al., "ESTROGEN-RECEPTOR GENE POLYMORPHISM IN POSTMENOPAUSAL PRIMARY HYPERPARATHYROIDISM", Surgery, 122(6), 1997, pp. 1101-1105
77. WESSON LG
    HOMEOSTASIS OF PHOSPHATE REVISITED
    Nephron
    
    L.G. Wesson, "HOMEOSTASIS OF PHOSPHATE REVISITED", Nephron, 77(3), 1997, pp. 249-266
78. MARTIN M; VIGO FD; MARTINEZ JI; LARRODERA ML; ORTEGA G
    INTRAOPERATIVE SERUM PARATHORMONE MEASURE MENT IN THE SURGICAL-TREATMENT OF HYPERPARATHYROIDISM
    Medicina Clinica
    
    M. Martin et al., "INTRAOPERATIVE SERUM PARATHORMONE MEASURE MENT IN THE SURGICAL-TREATMENT OF HYPERPARATHYROIDISM", Medicina Clinica, 109(6), 1997, pp. 201-206
79. HEIDBREDER E; NAUJOKS H; BROSA U; SCHRAMM L
    THE CALCIUM-PARATHYROID HORMONE REGULATION IN CHRONIC-RENAL-FAILURE INVESTIGATION OF ITS DYNAMIC SECRETION PATTERN
    Hormone and Metabolic Research
    
    E. Heidbreder et al., "THE CALCIUM-PARATHYROID HORMONE REGULATION IN CHRONIC-RENAL-FAILURE INVESTIGATION OF ITS DYNAMIC SECRETION PATTERN", Hormone and Metabolic Research, 29(2), 1997, pp. 70-75
80. LEE NE; REDDY GS; BROWN AJ; WILLIARD PG
    SYNTHESIS, STEREOCHEMISTRY, AND BIOLOGICAL-ACTIVITY OF 1-ALPHA,23,25-TRIHYDROXY-24-OXOVITAMIN D-3, A MAJOR NATURAL METABOLITE OF 1-ALPHA,25-DIHYDROXYVITAMIN D-3
    Biochemistry
    
    N.E. Lee et al., "SYNTHESIS, STEREOCHEMISTRY, AND BIOLOGICAL-ACTIVITY OF 1-ALPHA,23,25-TRIHYDROXY-24-OXOVITAMIN D-3, A MAJOR NATURAL METABOLITE OF 1-ALPHA,25-DIHYDROXYVITAMIN D-3", Biochemistry, 36(31), 1997, pp. 9429-9437
81. FELSENFELD AJ; RODRIGUEZ M
    THE SET-POINT OF CALCIUM - ANOTHER VIEW
    Nephrology, dialysis, transplantation
    
    A.J. Felsenfeld e M. Rodriguez, "THE SET-POINT OF CALCIUM - ANOTHER VIEW", Nephrology, dialysis, transplantation, 11(9), 1996, pp. 1722-1725
82. LIPPUNER K; ZEHNDER HJ; CASEZ JP; TAKKINEN R; DESCOEUDRES C; JAEGER P
    EFFECT OF CALCIUM-CHANNEL BLOCKERS ON CALCIUM-PHOSPHATE METABOLISM INPATIENTS WITH END-STAGE RENAL-DISEASE
    Nephrology, dialysis, transplantation
    
    K. Lippuner et al., "EFFECT OF CALCIUM-CHANNEL BLOCKERS ON CALCIUM-PHOSPHATE METABOLISM INPATIENTS WITH END-STAGE RENAL-DISEASE", Nephrology, dialysis, transplantation, 11(1), 1996, pp. 70-74
83. AGUILERATEJERO E; SANCHEZ J; ALMADEN Y; MAYERVALOR R; RODRIGUEZ M; FELSENFELD AJ
    HYSTERESIS OF THE PTH-CALCIUM CURVE DURING HYPOCALCEMIA IN THE DOG - EFFECT OF THE RATE AND LINEARITY OF CALCIUM DECREASE AND SEQUENTIAL EPISODES OF HYPOCALCEMIA
    Journal of bone and mineral research
    
    E. Aguileratejero et al., "HYSTERESIS OF THE PTH-CALCIUM CURVE DURING HYPOCALCEMIA IN THE DOG - EFFECT OF THE RATE AND LINEARITY OF CALCIUM DECREASE AND SEQUENTIAL EPISODES OF HYPOCALCEMIA", Journal of bone and mineral research, 11(9), 1996, pp. 1226-1233
84. HERMANS C; LEFEBVRE C; DEVOGELAER JP; LAMBERT M
    HYPOCALCEMIA AND CHRONIC ALCOHOL-INTOXICATION - TRANSIENT HYPOPARATHYROIDISM SECONDARY TO MAGNESIUM-DEFICIENCY
    Clinical rheumatology
    
    C. Hermans et al., "HYPOCALCEMIA AND CHRONIC ALCOHOL-INTOXICATION - TRANSIENT HYPOPARATHYROIDISM SECONDARY TO MAGNESIUM-DEFICIENCY", Clinical rheumatology, 15(2), 1996, pp. 193-196
85. GAUMET N; SEIBEL MJ; BRAILLON P; GIRY J; LEBECQUE P; DAVICCO MJ; COXAM V; ROUFFET J; DELMAS PD; BARLET JP
    INFLUENCE OF OVARIECTOMY ON BONE METABOLISM IN VERY OLD RATS
    Calcified tissue international
    
    N. Gaumet et al., "INFLUENCE OF OVARIECTOMY ON BONE METABOLISM IN VERY OLD RATS", Calcified tissue international, 58(4), 1996, pp. 256-262
86. BRANDI L; DAUGAARD H; NIELSEN PK; JENSEN LT; EGSMOSE C; OLEGAARD K
    LONG-TERM EFFECTS OF INTRAVENOUS 1-ALPHA(OH)D-3 COMBINED WITH CACO3 AND LOW-CALCIUM DIALYSIS ON SECONDARY HYPERPARATHYROIDISM AND BIOCHEMICAL BONE MARKERS IN PATIENTS ON CHRONIC-HEMODIALYSIS
    Nephron
    
    L. Brandi et al., "LONG-TERM EFFECTS OF INTRAVENOUS 1-ALPHA(OH)D-3 COMBINED WITH CACO3 AND LOW-CALCIUM DIALYSIS ON SECONDARY HYPERPARATHYROIDISM AND BIOCHEMICAL BONE MARKERS IN PATIENTS ON CHRONIC-HEMODIALYSIS", Nephron, 74(1), 1996, pp. 89-103
87. GAO P; SCHMIDTGAYK H; DITTRICH K; NOLTING B; MAIER A; ROTH HJ; SEEMANN O; REICHEL H; RITZ E; SCHILLING T
    IMMUNOCHEMILUMINOMETRIC ASSAY WITH 2 MONOCLONAL-ANTIBODIES AGAINST THE N-TERMINAL SEQUENCE OF HUMAN PARATHYROID-HORMONE
    Clinica chimica acta
    
    P. Gao et al., "IMMUNOCHEMILUMINOMETRIC ASSAY WITH 2 MONOCLONAL-ANTIBODIES AGAINST THE N-TERMINAL SEQUENCE OF HUMAN PARATHYROID-HORMONE", Clinica chimica acta, 245(1), 1996, pp. 39-59
88. TAKEUCHI K; FUJITA I; NAKAJIMA K; KITAGAKI S; KOKETSU I
    INFLUENCE OF MAGNESIUM-SULFATE TOCOLYSIS ON CALCIUM-METABOLISM
    Journal of maternal-fetal investigation
    
    K. Takeuchi et al., "INFLUENCE OF MAGNESIUM-SULFATE TOCOLYSIS ON CALCIUM-METABOLISM", Journal of maternal-fetal investigation, 5(4), 1995, pp. 226-229
89. HAMDY NAT
    THE NEED TO TREAT PREDIALYSIS PATIENTS
    Nephrology, dialysis, transplantation
    
    N.A.T. Hamdy, "THE NEED TO TREAT PREDIALYSIS PATIENTS", Nephrology, dialysis, transplantation, 10, 1995, pp. 19-22
90. NADLER JL; RUDE RK
    DISORDERS OF MAGNESIUM-METABOLISM
    Endocrinology and metabolism clinics of North America
    
    J.L. Nadler e R.K. Rude, "DISORDERS OF MAGNESIUM-METABOLISM", Endocrinology and metabolism clinics of North America, 24(3), 1995, pp. 623
91. DUMOULIN G; HORY B; NGUYEN NU; HENRIET MT; BRESSON C; REGNARD J; SAINTHILLIER Y
    ACUTE ORAL CALCIUM LOAD DECREASES PARATHYROID SECRETION AND SUPPRESSES TUBULAR PHOSPHATE LOSS IN LONG-TERM RENAL-TRANSPLANT RECIPIENTS
    American journal of nephrology
    
    G. Dumoulin et al., "ACUTE ORAL CALCIUM LOAD DECREASES PARATHYROID SECRETION AND SUPPRESSES TUBULAR PHOSPHATE LOSS IN LONG-TERM RENAL-TRANSPLANT RECIPIENTS", American journal of nephrology, 15(3), 1995, pp. 238-244
92. CHANG WH; CHEN TH; GARDNER P; SHOBACK D
    REGULATION OF CA2-CONDUCTING CURRENTS IN PARATHYROID CELLS BY EXTRACELLULAR CA2+ AND CHANNEL BLOCKERS()
    American journal of physiology: endocrinology and metabolism
    
    W.H. Chang et al., "REGULATION OF CA2-CONDUCTING CURRENTS IN PARATHYROID CELLS BY EXTRACELLULAR CA2+ AND CHANNEL BLOCKERS()", American journal of physiology: endocrinology and metabolism, 32(5), 1995, pp. 864-877
93. TUCKER K
    MICRONUTRIENT STATUS AND AGING
    Nutrition reviews
    
    K. Tucker, "MICRONUTRIENT STATUS AND AGING", Nutrition reviews, 53(9), 1995, pp. 9-15
94. FOURNIER A; MORINIERE P; OPRISIU R; YVERNEAUHARDY P; WESTEEL PF; MAZOUZ H; ELESPER N; GHAZALI A; BOUDAILLIEZ B
    1-ALPHA-HYDROXYVITAMIN-D-3 DERIVATIVES IN THE TREATMENT OF RENAL BONE-DISEASES - JUSTIFICATION AND OPTIMAL MODALITIES OF ADMINISTRATION
    Nephron
    
    A. Fournier et al., "1-ALPHA-HYDROXYVITAMIN-D-3 DERIVATIVES IN THE TREATMENT OF RENAL BONE-DISEASES - JUSTIFICATION AND OPTIMAL MODALITIES OF ADMINISTRATION", Nephron, 71(3), 1995, pp. 254-283
95. MCKANE WR; KHOSLA S; BURRITT MF; KAO PC; WILSON DM; ORY SJ; RIGGS BL
    MECHANISM OF RENAL CALCIUM CONSERVATION WITH ESTROGEN REPLACEMENT THERAPY IN WOMEN IN EARLY POSTMENOPAUSE - A CLINICAL RESEARCH-CENTER STUDY
    The Journal of clinical endocrinology and metabolism
    
    W.R. Mckane et al., "MECHANISM OF RENAL CALCIUM CONSERVATION WITH ESTROGEN REPLACEMENT THERAPY IN WOMEN IN EARLY POSTMENOPAUSE - A CLINICAL RESEARCH-CENTER STUDY", The Journal of clinical endocrinology and metabolism, 80(12), 1995, pp. 3458-3464
96. HEIDBREDER E; NAUJOKS H; BROSA U; SCHRAMM L; GOTZ R
    PARATHYROID-HORMONE SECRETION AND SERUM-CALCIUM CONCENTRATION - A DETERMINISTIC VIEW OF ITS REGULATION
    Hormone and Metabolic Research
    
    E. Heidbreder et al., "PARATHYROID-HORMONE SECRETION AND SERUM-CALCIUM CONCENTRATION - A DETERMINISTIC VIEW OF ITS REGULATION", Hormone and Metabolic Research, 27(5), 1995, pp. 244-250
97. LIOU HH; CHIANG SS; HUANG TP; SHIEH SD; AKMAL M
    COMPARATIVE EFFECT OF ORAL OR INTRAVENOUS CALCITRIOL ON SECONDARY HYPERPARATHYROIDISM IN CHRONIC-HEMODIALYSIS PATIENTS
    Mineral and electrolyte metabolism
    
    H.H. Liou et al., "COMPARATIVE EFFECT OF ORAL OR INTRAVENOUS CALCITRIOL ON SECONDARY HYPERPARATHYROIDISM IN CHRONIC-HEMODIALYSIS PATIENTS", Mineral and electrolyte metabolism, 20(3), 1994, pp. 97-102
98. ABBOTT L; NADLER J; RUDE RK
    MAGNESIUM-DEFICIENCY IN ALCOHOLISM - POSSIBLE CONTRIBUTION TO OSTEOPOROSIS AND CARDIOVASCULAR-DISEASE IN ALCOHOLICS
    Alcoholism, clinical and experimental research
    
    L. Abbott et al., "MAGNESIUM-DEFICIENCY IN ALCOHOLISM - POSSIBLE CONTRIBUTION TO OSTEOPOROSIS AND CARDIOVASCULAR-DISEASE IN ALCOHOLICS", Alcoholism, clinical and experimental research, 18(5), 1994, pp. 1076-1082
99. KOTZMANN H; SVOBODA T; BERNECKER P; CLODI M; WOLOSZCZUK W; NIEDERLE B; WALDHAUSL W; LUGER A
    DISODIUMPAMIDRONATE (APD) - AN EFFECTIVE DRUG IN THE TREATMENT OF HYPERACALCEMIA IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM
    Wiener Klinische Wochenschrift
    
    H. Kotzmann et al., "DISODIUMPAMIDRONATE (APD) - AN EFFECTIVE DRUG IN THE TREATMENT OF HYPERACALCEMIA IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM", Wiener Klinische Wochenschrift, 106(13), 1994, pp. 422-425
100. HOROWITZ M; WISHART JM; NEED AG; MORRIS HA; NORDIN BEC
     BIOCHEMICAL EFFECTS OF A CALCIUM SUPPLEMENT IN POSTMENOPAUSAL WOMEN WITH PRIMARY HYPERPARATHYROIDISM
     Hormone and Metabolic Research
     
     M. Horowitz et al., "BIOCHEMICAL EFFECTS OF A CALCIUM SUPPLEMENT IN POSTMENOPAUSAL WOMEN WITH PRIMARY HYPERPARATHYROIDISM", Hormone and Metabolic Research, 26(1), 1994, pp. 39-42